in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Perrigo's API Business Reports Rise in Sales, Operating Profits
8:35 AM MDT | August 17, 2012 | Deepti Ramesh
The active pharmaceutical ingredient (API) business segment of Perrigo (Allegan, MI) reported a 4.3% rise in sales in its fiscal fourth quarter, ended June 30, 2012, compared with the year-ago period, to $38.4 million. Fourth-quarter operating profits for the API business tripled, to $18 million. The performance of the API segment was favorably impacted by a commercial agreement with a customer to supply a generic product that was launched in the fourth quarter, and which unexpectedly received a 180-day exclusivity status, Perrigo says. For the full...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee